Clinical Trial Update: Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating pregabalin for treatment response prediction in postherpetic neuralgia; the trial was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Postherpetic Neuralgia | Phase 4 | Status: TERMINATED | Results posted: 2014-07-08